---
title: Rates of Strokes in Californians with Sickle Cell Disease in the Post-STOP
  Era
date: '2024-09-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39302175/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240920192703&v=2.18.0.post9+e462414
source: Blood
description: Neurovascular complications, including strokes and transient ischemic
  attacks (TIAs), are common and cause significant morbidity in individuals with sickle
  cell disease (SCD). The STOP trial (1998) established chronic transfusions as the
  standard of care for children with SCD at high risk for stroke. Using statewide
  emergency department and hospitalization data from the California Department of
  Health Care Access and Innovation (1991-2019), we determined the cumulative incidence
  and rates ...
disable_comments: true
---
Neurovascular complications, including strokes and transient ischemic attacks (TIAs), are common and cause significant morbidity in individuals with sickle cell disease (SCD). The STOP trial (1998) established chronic transfusions as the standard of care for children with SCD at high risk for stroke. Using statewide emergency department and hospitalization data from the California Department of Health Care Access and Innovation (1991-2019), we determined the cumulative incidence and rates ...